Search Results 1891-1900 of 19159 for Enzyme

1. MDM2 Inhibitor AMG-232 and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma - Mayo Clinic

   MDM2 inhibitor AMG-232 may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving MDM2 inhibitor AMG-232 and ...

2. Trametinib, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery - Mayo Clinic

   Trametinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as carboplatin and ...

3. Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer - Mayo Clinic

   Dabrafenib and trametinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal ...

4. Sulfadiazine (oral route) - Side effects & dosage - Mayo Clinic

   Glucose-6-phosphate dehydrogenase (G6PD) deficiency (an enzyme problem) or; Kidney disease or; Liver disease—Use with caution. May have an increased chance of ...

5. Spontaneous coronary artery dissection: Hidden in plain sight - Mayo Clinic

   Empiric medical management (single antiplatelet agent, beta blocker, angiotensin-converting enzyme inhibitor therapy if appropriate) and close observation are ...

6. Panobinostat and Everolimus in Treating Patients with Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma - Mayo Clinic

   Panobinostat and everolimus may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Participation eligibility.

7. Clinical trials - Oncology (Medical)

   Olaparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as temozolomide, work ...

8. Radiation Therapy For Breast Cancer Clinical Trials - Mayo Clinic Research

   Olaparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It is not yet known whether radiation therapy with or ...

9. A Study of ABC294640 (Yeliva®) in the Treatment of Patients with Advanced Cholangiocarcinoma - Mayo Clinic

   The study drug, ABC294640 is an orally available inhibitor of the enzyme sphingosine kinase-2 (SK2). SK2 is an innovative target for anti-cancer therapy ...

10. Diabetic neuropathy: Can dietary supplements help? - Mayo Clinic

    Along with a healthy diet, some vitamin and antioxidant products might play a role in preventing or slowing this common diabetes complication.